v3.26.1
Statement of Changes in Cash Flows Unaudited - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating activities    
Net income (loss) $ (2,213,391) $ 742,870
Adjustments for non-cash items in net income (loss) and earnings impact of warrant liability reclassification:    
Depreciation of property and equipment 91,162 104,984
Depreciation of property and equipment included in costs of finished cannabis inventory sold 822,531 315,216
Lease costs included in costs of finished cannabis inventory sold 199,415 34,055
Share-based compensation 154,994 1,435,910
Interest and accretion expense 549,980 258,171
Other income (41,501)
Interest income (42,187) (35,937)
Unrealized (gain) loss on derivative liability (66,377) (2,864,373)
Realized (gain) loss on derivative liability 29,288
Unrealized loss on warrant asset 2,191,084 1,172,492
Unrealized gain on warrant liability (770,714)
Loss on equity investment in associate 99,657 153,734
Deferred income taxes (421,318) (63,418)
Changes in operating assets and liabilities (Note 19) 1,939,688 (2,246,071)
Net cash provided by (used in) operating activities 2,534,524 (1,004,580)
Investing activities    
Purchase of property and equipment (2,517,414) (241,532)
Payments of business acquisition consideration payable (157,199) (43,290)
Investment in Rogue EBC, LLC equity interest (200,000) (49,000)
Net cash used in investing activities (2,874,613) (333,822)
Financing activities    
Sale of non-controlling interest in GRMA, net of issuance costs 2,985,000
Preferred share issuance costs
Proceeds from exercise of stock options 21,839 16,038
Proceeds from long-term debt 500,000 7,250,155
Distributions to non-controlling interests in subsidiaries (85,156)
Debt issuance costs (213,373)
Repayment of long-term debt (733,431) (732,004)
Payment of interest on convertible debentures (75,529)
Repayment of finance lease (18,750)
Net cash provided by financing activities 2,669,502 6,245,287
Effect of foreign exchange on cash and cash equivalents 7,832
Change in cash and cash equivalents 2,329,413 4,906,885
Cash and cash equivalents, beginning of period 11,371,834 4,917,708
Cash and cash equivalents, ending of period $ 13,701,247 $ 9,832,425

Source

10-Q XBRL Zip